479 related articles for article (PubMed ID: 18502503)
41. Asparaginase use for the treatment of acute lymphoblastic leukemia.
Barba P; Dapena JL; Montesinos P; Rives S
Med Clin (Barc); 2017 Mar; 148(5):225-231. PubMed ID: 28118965
[No Abstract] [Full Text] [Related]
42. The best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?
Pinheiro JP; Boos J
Br J Haematol; 2004 Apr; 125(2):117-27. PubMed ID: 15059133
[No Abstract] [Full Text] [Related]
43. Diabetic ketoacidosis and persistent hyperglycemia as long-term complications of L-asparaginase-induced pancreatitis.
Hsu YJ; Chen YC; Ho CL; Kao WY; Chao TY
Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):441-5. PubMed ID: 12433031
[TBL] [Abstract][Full Text] [Related]
44. [Hyperglycemia as a side effect of using L-asparaginase in children with acute lymphoblastic leukemia (ALL].
Brodkiewicz A; Kamieńska E; Urasiński T; Peregud-Pogorzelski J
Acta Haematol Pol; 1995; 26(1):99-101. PubMed ID: 7747569
[TBL] [Abstract][Full Text] [Related]
45. L-asparaginase induced severe hypertriglyceridemia in acute lymphoblastic leukemia with 11q23 abnormality.
Jain S; Naithani R; Kapoor G; Nath T
Leuk Res; 2009 Nov; 33(11):e194. PubMed ID: 19487026
[No Abstract] [Full Text] [Related]
46. Increased serum trypsin and elastase-1 levels in patients undergoing L-asparaginase therapy.
Shimizu T; Yamashiro Y; Igarashi J; Fujita H; Ishimoto K
Eur J Pediatr; 1998 Jul; 157(7):561-3. PubMed ID: 9686816
[TBL] [Abstract][Full Text] [Related]
47. Successful management of a child with asparaginase-induced hemorrhagic pancreatitis.
Lamelas RG; Chapchap P; Magalhaes AC; Filho JO; Mendes WL; de Camargo B
Med Pediatr Oncol; 1999 Apr; 32(4):316. PubMed ID: 10102033
[No Abstract] [Full Text] [Related]
48. Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia
.
Thu Huynh V; Bergeron S
Clin J Oncol Nurs; 2017 Oct; 21(5):E248-E259. PubMed ID: 28945721
[TBL] [Abstract][Full Text] [Related]
49. [Fulminant hepatitis possibly caused by L-asparaginase during induction chemotherapy in a patient with acute lymphoblastic leukemia].
Tsutsui M; Koike M; Komatsu N
Rinsho Ketsueki; 2012 May; 53(5):531-4. PubMed ID: 22728556
[TBL] [Abstract][Full Text] [Related]
50. [Successful readministration of L-asparaginase after development of severe hypertriglyceridemia in a young adult with T-cell acute lymphoblastic leukemia].
Watanabe K; Yoshifuji K; Ohkawa R; Tozuka M; Miura O; Arai A
Rinsho Ketsueki; 2018; 59(12):2555-2560. PubMed ID: 30626788
[TBL] [Abstract][Full Text] [Related]
51. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
[No Abstract] [Full Text] [Related]
52. Isolated pericardial and mediastinal relapse following allogeneic bone marrow transplantation for acute lymphoblastic leukemia.
Facon T; Jouet JP; Fenaux P; Walter MP; Lai JL; Jabinet JL; Chambon JP; Bauters F
Transplantation; 1991 May; 51(5):1125-6. PubMed ID: 2031267
[No Abstract] [Full Text] [Related]
53. Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia.
Nomdedéu J; Martino R; Sureda A; Huidobro G; López R; Brunet S; Domingo-Albós A
Bone Marrow Transplant; 1994 May; 13(5):659-60. PubMed ID: 8054919
[TBL] [Abstract][Full Text] [Related]
54. The molecular perspective: l-asparaginase.
Goodsell DS
Stem Cells; 2005 May; 23(5):710-1. PubMed ID: 15849179
[No Abstract] [Full Text] [Related]
55. [Allogeneic stem cell transplantation for patients with Philadelphia positive leukemia resistant to imatinib].
Han W; Liu KY; Xu LP; Chen H; Liu DH; Chen YH; Zhang XH; Zhang YC; Chen Y; Wang Y; Wang J; Lu DP; Huang XJ
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1974-7. PubMed ID: 19062738
[TBL] [Abstract][Full Text] [Related]
56. Impact of allogeneic haematopoietic stem cell transplantation in the outcome of Ph+ acute lymphoblastic leukaemia treated with an imatinib-containing regimen.
Costa LJ
Br J Haematol; 2009 Sep; 146(5):576-7. PubMed ID: 19555375
[No Abstract] [Full Text] [Related]
57. Thyroid function is not affected by second exposure to erwinia asparaginase for childhood acute lymphoblastic leukemia.
Bossi G; Larizza D; Conter V
Haematologica; 1997; 82(4):507-8. PubMed ID: 9299875
[No Abstract] [Full Text] [Related]
58. Successful management of extreme hypertriglyceridemia in a child with acute lymphoblastic leukemia by temporarily omitting dexamethasone while continuing asparaginase.
Tong WH; Pieters R; van der Sluis IM
Pediatr Blood Cancer; 2012 Feb; 58(2):317-8. PubMed ID: 22162400
[No Abstract] [Full Text] [Related]
59. [Advances on the role of pegaspargase in the treatment of childhood leukemia].
Liu L; Xie XT
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):155-60. PubMed ID: 24568909
[TBL] [Abstract][Full Text] [Related]
60. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.
Rathi B; Azad RK; Vasudha N; Hissaria P; Sawlani V; Gupta RK
Pediatr Neurosurg; 2002 Oct; 37(4):203-5. PubMed ID: 12372914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
